MELKs as modifiers of the RAC pathway and methods of use

Details for Australian Patent Application No. 2004264936 (hide)

Owner Exelixis, Inc.

Inventors Lickteig, Kim; Kadyk, Lisa; Heuer, Timothy S.; Francis, George Ross

Agent Davies Collison Cave

Pub. Number AU-A-2004264936

PCT Pub. Number WO2005/016279

Priority 60/495,193 14.08.03 US

Filing date 12 August 2004

Wipo publication date 24 February 2005

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/016279 Priority application(s): WO2005/016279

18 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264937-Quinazoline analogs as receptor tyrosine kinase inhibitors

2004264927-Bone supporting devices with bioabsorbable end members